choline alfoscerate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 627 | 28319-77-9 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | N07AX02 | NERVOUS SYSTEM OTHER NERVOUS SYSTEM DRUGS PARASYMPATHOMIMETICS Other parasympathomimetics |
| MeSH PA | D000963 | Antimetabolites |
| MeSH PA | D002491 | Central Nervous System Agents |
| MeSH PA | D005765 | Gastrointestinal Agents |
| MeSH PA | D000960 | Hypolipidemic Agents |
| MeSH PA | D057847 | Lipid Regulating Agents |
| MeSH PA | D008082 | Lipotropic Agents |
| MeSH PA | D018697 | Nootropic Agents |
| CHEBI has role | CHEBI:25512 | neurotransmitters |
| CHEBI has role | CHEBI:33284 | nutrients |
| CHEBI has role | CHEBI:50904 | alergeno |
| CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
| CHEBI has role | CHEBI:75772 | S. cerevisiae metabolites |
| CHEBI has role | CHEBI:76924 | plant metabolites |
| CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
| CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
| CHEBI has role | CHEBI:83056 | Daphnia magna metabolites |
| CHEBI has role | CHEBI:50370 | parasympatholytics |
| CHEBI has role | CHEBI:63726 | neuroprotective agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 1.2 | acidic |
| pKa2 | 13.63 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| N0000168626 | NUI |
| D07349 | KEGG_DRUG |
| 2449 | RXNORM |
| 4017699 | VANDF |
| C0017889 | UMLSCUI |
| CHEBI:16870 | CHEBI |
| CHEBI:15354 | CHEBI |
| CHEMBL1567463 | ChEMBL_ID |
| DB04660 | DRUGBANK_ID |
| 657272 | PUBCHEM_CID |
| 5203 | INN_ID |
| 60M22SGW66 | UNII |
| 4436 | MMSL |
| 4875 | MMSL |
| d03159 | MMSL |
| 002058 | NDDF |
| 006975 | NDDF |
| 111156002 | SNOMEDCT_US |
| 65123005 | SNOMEDCT_US |
| C0008405 | UMLSCUI |
| CH5 | PDB_CHEM_ID |
| DB00122 | DRUGBANK_ID |
| D002794 | MESH_DESCRIPTOR_UI |
| 305 | PUBCHEM_CID |
Pharmaceutical products:
None